Stemline Therapeutics, Inc.

Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build a leading biopharmaceutical company focused on improving the lives of cancer patients by developing and commercializing novel first-in-class therapeutics. Our primary focus at Stemline is to discover and develop innovative therapies, and we are deeply committed to ensuring our products are available to patients around the globe. Below is our current pipeline of medicines.